submit url add directory Physician Assistant jobs ♦ Nurse Practitioner jobs
Related Topics:
Diagnostic RadiologyRadiology
Nuclear Pharmacy :: Pharmacy
Health Physics and Radiological Health :: Environmental Health
Today's News:
All Nuclear Medicine Jobs
Nuclear Medicine jobs
Thu, 09 Feb 2012 18:59:52 -0500
All Nuclear Medicine jobs for Thu Feb 9 2012
Nuclear Medicine jobs in "Statewide" - VA
Mon, 10 May 2010 13:27:44 -0500
Looking for a job in a big city? Even if you've heard that a market is "saturated", we can help! Many job openings for physicians may be hidden and unavailable unless you know where to look. An excellent
Nuclear Medicine jobs in "Statewide" - TX
Mon, 10 May 2010 13:27:44 -0500
Looking for a job in a big city? Even if you've heard that a market is "saturated", we can help! Many job openings for physicians may be hidden and unavailable unless you know where to look. An excellent
pubmed: 0161-5505
Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET.
Van Nostrand D, Khorjekar GR, O'Neil J, Moreau S, Atkins FB, Kharazi P, Mete M, Chennupati SP, Burman KD, Wartofsky L Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET. J Nucl Med. 2012 Feb 7; Authors: Van Nostrand D, Khorjekar GR, O'Neil J, Moreau S, Atkins FB, Kharazi P, Mete M, Chennupati SP, Burman KD, Wartofsky L Abstract Various studies have compared the detection of functioning residual thyroid tissue after thyroidectomy using radioiodine whole-body (WB) imaging following preparation of patients with injections of recombinant human thyroid-stimulating hormone (rhTSH) and thyroid hormone withdrawal (THW). However, metastases may have radiopharmacokinetics different from normal thyroid tissue. The objective of this study was to evaluate these 2 methods of patient preparation for the detection of metastases from differentiated thyroid cancer (DTC) using (131)I WB imaging and (124)I PET. METHODS: A prospective study approved by the institutional review board was conducted at Washington Hospital Center from 2006 to 2010 recruiting patients who had DTC, were suspected of having metastasis from DTC (e.g., elevated thyroglobulin level without thyroglobulin antibodies, positive results on recent fine-needle aspiration, suspected enlarging mass, and abnormal findings suggesting metastasis on a diagnostic study) and were referred for (131)I WB dosimetry. All patients subsequently underwent both (131)I WB imaging and (124)I PET performed using the same preparation. All foci of uptake identified on these scans were categorized in a masked manner by consensus of 2 physicians in the following manner: 1, definite physiologic uptake or artifact; 2, most likely physiologic uptake or artifact; 3, indeterminate; 4, most likely locoregional metastases in the neck bed; 5, most likely distant metastases; or 6, definite distant metastases. Foci categorized as 4, 5, and 6 were considered positive for functioning metastases. RESULTS: Of 40 patients evaluated, 24 patients were prepared with rhTSH and 16 with THW. No statistical difference was noted between the 2 groups for any of the parameters evaluated, including serum thyroglobulin. The percentages of patients with positive foci detected on the rhTSH (131)I and THW (131)I WB scans were 4% (1/24) and 63% (10/16), respectively (P < 0.02). The number of foci detected on the rhTSH (131)I and THW (131)I WB scans were 2 and 58, respectively (P < 0.05). When (124)I PET was used for imaging, the percentages of patients with foci detected on the rhTSH and THW scans were 29% (7/24) and 63% (10/16), respectively (P < 0.03). The number of foci detected on the rhTSH and THW scans were 17 and 117, respectively (P < 0.03). CONCLUSION: Significantly more foci of metastases of DTC may be identified in patients prepared with THW than in patients prepared with rhTSH. PMID: 22315442 [PubMed - as supplied by publisher]
Risk Stratification of Gallbladder Polyps (1-2 cm) for Surgical Intervention with 18F-FDG PET/CT.
Lee J, Yun M, Kim KS, Lee JD, Kim CK Risk Stratification of Gallbladder Polyps (1-2 cm) for Surgical Intervention with 18F-FDG PET/CT. J Nucl Med. 2012 Feb 7; Authors: Lee J, Yun M, Kim KS, Lee JD, K
Subscribe to Nuclear_Medicine RSS feed 
Nuclear Medicine jobs
Thu, 09 Feb 2012 18:59:52 -0500
All Nuclear Medicine jobs for Thu Feb 9 2012
Nuclear Medicine jobs in "Statewide" - VA
Mon, 10 May 2010 13:27:44 -0500
Looking for a job in a big city? Even if you've heard that a market is "saturated", we can help! Many job openings for physicians may be hidden and unavailable unless you know where to look. An excellent
Nuclear Medicine jobs in "Statewide" - TX
Mon, 10 May 2010 13:27:44 -0500
Looking for a job in a big city? Even if you've heard that a market is "saturated", we can help! Many job openings for physicians may be hidden and unavailable unless you know where to look. An excellent
pubmed: 0161-5505
Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET.
Van Nostrand D, Khorjekar GR, O'Neil J, Moreau S, Atkins FB, Kharazi P, Mete M, Chennupati SP, Burman KD, Wartofsky L Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET. J Nucl Med. 2012 Feb 7; Authors: Van Nostrand D, Khorjekar GR, O'Neil J, Moreau S, Atkins FB, Kharazi P, Mete M, Chennupati SP, Burman KD, Wartofsky L Abstract Various studies have compared the detection of functioning residual thyroid tissue after thyroidectomy using radioiodine whole-body (WB) imaging following preparation of patients with injections of recombinant human thyroid-stimulating hormone (rhTSH) and thyroid hormone withdrawal (THW). However, metastases may have radiopharmacokinetics different from normal thyroid tissue. The objective of this study was to evaluate these 2 methods of patient preparation for the detection of metastases from differentiated thyroid cancer (DTC) using (131)I WB imaging and (124)I PET. METHODS: A prospective study approved by the institutional review board was conducted at Washington Hospital Center from 2006 to 2010 recruiting patients who had DTC, were suspected of having metastasis from DTC (e.g., elevated thyroglobulin level without thyroglobulin antibodies, positive results on recent fine-needle aspiration, suspected enlarging mass, and abnormal findings suggesting metastasis on a diagnostic study) and were referred for (131)I WB dosimetry. All patients subsequently underwent both (131)I WB imaging and (124)I PET performed using the same preparation. All foci of uptake identified on these scans were categorized in a masked manner by consensus of 2 physicians in the following manner: 1, definite physiologic uptake or artifact; 2, most likely physiologic uptake or artifact; 3, indeterminate; 4, most likely locoregional metastases in the neck bed; 5, most likely distant metastases; or 6, definite distant metastases. Foci categorized as 4, 5, and 6 were considered positive for functioning metastases. RESULTS: Of 40 patients evaluated, 24 patients were prepared with rhTSH and 16 with THW. No statistical difference was noted between the 2 groups for any of the parameters evaluated, including serum thyroglobulin. The percentages of patients with positive foci detected on the rhTSH (131)I and THW (131)I WB scans were 4% (1/24) and 63% (10/16), respectively (P < 0.02). The number of foci detected on the rhTSH (131)I and THW (131)I WB scans were 2 and 58, respectively (P < 0.05). When (124)I PET was used for imaging, the percentages of patients with foci detected on the rhTSH and THW scans were 29% (7/24) and 63% (10/16), respectively (P < 0.03). The number of foci detected on the rhTSH and THW scans were 17 and 117, respectively (P < 0.03). CONCLUSION: Significantly more foci of metastases of DTC may be identified in patients prepared with THW than in patients prepared with rhTSH. PMID: 22315442 [PubMed - as supplied by publisher]
Risk Stratification of Gallbladder Polyps (1-2 cm) for Surgical Intervention with 18F-FDG PET/CT.
Lee J, Yun M, Kim KS, Lee JD, Kim CK Risk Stratification of Gallbladder Polyps (1-2 cm) for Surgical Intervention with 18F-FDG PET/CT. J Nucl Med. 2012 Feb 7; Authors: Lee J, Yun M, Kim KS, Lee JD, K

Sites:
American Board of Nuclear Medicine: The Board advances the health of the public through the establishment and maintenance of standards of training, and education, and the qualification of physicians rendering nuclear medicine services to the people of the United States.American College of Nuclear Physicians: A trade association that represents the interests of nuclear medicine physicians before legislative and regulatory bodies, other medical organizations, the media and general public.
American Society of Nuclear Cardiology: The American Society of Nuclear Cardiology is a professional medical society whose mission is to foster optimal delivery of nuclear cardiology services through professional education and training, the development of clinical guidelines, and the promotion of research.
Australian and New Zealand Society of Nuclear Medicine: About their history, branches, as well as their meetings and publications. Membership forms online.
British Nuclear Medicine Society: The British Nuclear Medicine Society web site gives information on medical events, adverse drug reactions and all other relevant information on nuclear medicine
Clinical Nuclear Medicine: Published monthly, with free abstracts, archived articles, and supscription details.
CNMT: Specializes in finding nuclear medicine jobs for nuclear medicine technologists.
CNR Nuclear Medicine Center: Research institute of the Italian National Research Council, focusing on diagnostic imaging of the central nervous system.
DrSpectScan.com: brain spect scanning and analysis, including before,and after any type of therapy for brain dysfunction. (analyses will be extended to the developing contributionsthat will come via PET and fMRI scanning), all modalities of bra...
European Association of Nuclear Medicine: European Association of Nuclear Medicine, Hollandstrasse 14 / Mezzanine, A-1020 Vienna, Austria Phone, +43 -1 - 2 12 80 30, Fax +43 -1 - 2 12 80 309
Hellenic Society of Nuclear Medicine: Based in Thessaloniki, Greece. Includes the Hellenic Journal of Nuclear Medicine.
History of Positron Imaging: A HISTORY OF POSITRON IMAGING
How Stuff Works: Nuclear Medicine: Nuclear materials get used in many forms of nuclear medicine -- everything from PET scans to chemotherapy uses them! Learn how nuclear medicine works!
Imaginis - Nuclear medicine imaging: Award-winning, breast cancer information and news resource. Imaginis also covers related breast cancer health topics such as hormone replacement therapy (HRT), heart disease, multiple sclerosis, osteoporosis, cervical cancer, and ovarian cancer, as well as, extensive information about medical pr...
Joint Program in Nuclear Medicine: Information on this program from Harvard Medical School.
Nuclear Imaging Westmead: Nuclear Imaging Westmead provides a full range of Nuclear imaging services including traditional radiology and advanced imaging to the health care sector.
Nuclear Medicine Communications: Monthly journal of the BNMS publishing research and clinical work in all areas of nuclear medicine. Submission guidelines and subscription details available.
Nuclear Medicine Information: This site provides information and breaking news about nuclear medicine, PET and related technologies.
Nuclear Medicine jobs: Nuclear Medicine jobs are listed at Physician Employment. You may register to be automatically updated when new jobs are listed.
Nuclear Medicine on the Net: This site features case studies and interactive case forums amongst other physician information resources, and gives a brief history of the topic for the layperson. [Uses Frames]
Nuclear Medicine Research Council: Provides a topical introduction, as well as its use in treating disease and the production and use of radioisotopes.
Nuclear Medicine Technology Resource: Nuclear Medicine Technology Resource WebSite
Positron Emission Tomography: Current and accurate information for patients about Nuclear Medicine, PET. Learn what you might experience, how to prepare for the exam, benefits, risks and more.
Positron Emission Tomography in oncology: Information is provided about the use of dynamic PET, including compartment modeling and parametric imaging, for cancer therapy management.
Radiation Emergency Assistance Center/Training Site: REAC/TS is available 24/7 to provide emergency medical services or advice/consultation related to incidents involving radiological or nuclear materials.
RadiologyInfo: Nuclear Medicine procedure menu
Society of Nuclear Medicine: An international scientific and professional organization founded in 1954 to promote the science, technology and practical application of nuclear medicine.
University of Kansas - Nuclear Medicine: Details about their program and equipment, radiopharamaceutics, quality control, radioimmunoassay and PET. Large collection of clinical and research teaching files.
